CoChat

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial

Open access
Ajjan, Ramzi A, Jackson, Neil, Thomson, Scott A · 2019 · Diabetes and Vascular Disease Research

Abstract

Aim: Analyse the effects of professional flash glucose monitoring system (FreeStyle Libre Pro™) on glycaemic control in insulin-treated type 2 diabetes. Methods: Primary (n = 17) and secondary care centres (n = 5) randomised 148 type 2 diabetes patients into three groups: (A) self-monitoring of blood glucose (n = 52), (B) self-monitoring of blood glucose and two Libre Pro sensor wears (n = 46) or (C) self-monitoring of blood glucose and four sensor wears (n = 50). Primary endpoint was time in range (glucose 3.9–10 mmol/L) within group C comparing baseline with days 172–187. Predefined secondary endpoints included HbA1c, hypoglycaemia and quality of life measures analysed within and between groups (clinicaltrials.gov, NCT02434315). Results: In group C, time in range in the first 14 days (baseline) and days 172–187 was similar at 15.0 ± 5.0 and 14.1 ± 4.7 h/day (mean ± SD), respectively, (p = 0.1589). In contrast, HbA1c reduced from baseline to study end within group C by 4.9 ± 8.8 mmol/mol (0.44% ± 0.81%; p = 0.0003). HbA1c was also lower in group C compared with A at study end by 5.4 ± 1.79 mmol/mol (0.48% ± 0.16%; p = 0.0041, adjusted mean ± SE), without increased time in hypoglycaemia ( p = 0.1795). Treatment satisfaction scores improved in group C compared with A ( p = 0.0225) and no device-related serious adverse events were reported. Conclusions: Libre Pro can improve HbA1c and treatment satisfaction without increasing hypoglycaemic exposure in insulin-treated type 2 diabetes individuals managed in primary/secondary care centres.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1479164119827456

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Trial design. Following consent, screening and enrolment, all participants had a professional flash sensor applied to the upper arm for the 14-day baseline period. Participants with baseline sensor data of ⩾500 sensor glucose readings were randomised to one of the three study groups as shown.
Figure 1. Trial design. Following consent, screening and enrolment, all participants had a professional flash sensor applied to the upper arm for the 14-day baseline period. Participants with baseline sensor data of ⩾500 sensor glucose readings were randomised to one of the three study groups as shown.CC BY · PubMed Central
Figure 2. Trial profile demonstrating withdrawal rate.
Figure 2. Trial profile demonstrating withdrawal rate.CC BY · PubMed Central
Figure 3. Time in (a) glucose range 3.9–10 mmol/L and (b) HbA1c, during the baseline and treatment phases.
Figure 3. Time in (a) glucose range 3.9–10 mmol/L and (b) HbA1c, during the baseline and treatment phases.CC BY · PubMed Central
Figure 4. Time in (a) hypoglycaemia <3.9 mmol/L, (b) hyperglycaemia >10 mmol/L and (c) hyperglycemia >13.3 mmol/L, during the baseline and treatment phases.
Figure 4. Time in (a) hypoglycaemia <3.9 mmol/L, (b) hyperglycaemia >10 mmol/L and (c) hyperglycemia >13.3 mmol/L, during the baseline and treatment phases.CC BY · PubMed Central
Figure 5. Scores from the DTSQ Questionnaire for (a) total treatment satisfaction score and (b) perceived frequency of hyperglycaemia and hypoglycaemia.
Figure 5. Scores from the DTSQ Questionnaire for (a) total treatment satisfaction score and (b) perceived frequency of hyperglycaemia and hypoglycaemia.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 3

  1. Casagrande SS, 2013, Diabetes Care, 36, 2271
  2. Mohan V, 2016, J Assoc Physicians India, 64, 16
  3. Bergenstal RM, 2017, Presented at the American Diabetes Association 77th scientific sessions

Cited by

See all 79

Metadata

Authors
Ajjan, R. A., Jackson, N., & Thomson, S. A.
Affiliations
  • University of Leeds (GB)
  • Pound Hill Medical Group, Crawley, UK
  • Atherstone Surgery, Atherstone, UK
Corresponding author
Ajjan, Ramzi A
Venue
Diabetes and Vascular Disease Research
Published
2019-07
Volume
16
Issue
4
Pages
385-395
ISSN
  • 1479-1641 (ISSN-L)
  • 1752-8984
OpenAlex
W2953834345
Cited by
79
References
29
Citations by year
2026: 4 · 2025: 9 · 2024: 14 · 2023: 14 · 2022: 12 · 2021: 15 · 2020: 7 · 2019: 4
FWCI
7.71
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Diabetes and Vascular Disease Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
abbott diabetes care
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
flash glucose monitoring, FreeStyle Libre Pro, type 2 diabetes, insulin therapy, glycemic control, HbA1c reduction, time in range, hypoglycemia, self-monitoring of blood glucose, treatment satisfaction, primary and secondary care
MeSH terms
Aged, Blood Glucose, Diabetes Mellitus, Type 2, England, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Pilot Projects, Predictive Value of Tests, Primary Health Care, Prospective Studies, Time Factors, Blood Glucose Self-Monitoring, Biomarkers, Down-Regulation, Treatment Outcome, Patient Satisfaction, Secondary Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial. https://app.cochat.ai/papers/10.1177/1479164119827456
The paper
Ajjan, R. A., Jackson, N., & Thomson, S. A. (2019). Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial. Diabetes and Vascular Disease Research. https://doi.org/10.1177/1479164119827456

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.